Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2021-02-09 23:25 2021-02-09 BOLT Bolt Biotherapeutics, Inc. ENGLEMAN EDGAR Director, 10% owner Pharmaceutical Preparations BUY $20.00 200,000 $4,000,000 275,789 +263.9%
2021-02-10 02:04 2021-02-09 BOLT Bolt Biotherapeutics, Inc. Sofinnova Venture Partners X, L.P. 10% owner Pharmaceutical Preparations BUY $20.00 450,000 $9,000,000 2,754,437 +19.5%
2021-02-10 00:30 2021-02-08 NRGX PIMCO Dynamic Income Strategy Fund IVASCYN DANIEL J Other Other BUY $9.29 500,000 $4,644,900 1,251,001 +66.6%
2021-02-10 03:20 2021-02-05 LABP N/A PERCEPTIVE ADVISORS LLC Director, 10% owner Other BUY $12.84 250,187 $3,212,451 7,299,751 +3.5%
2021-02-10 04:47 2021-02-03 ONTF ON24 INC. GOLDMAN SACHS GROUP INC 10% owner Services-Prepackaged Software BUY $74.75 87,822 $6,564,905 85,622 +100.0%
2021-02-10 01:10 2021-02-05 NOG NORTHERN OIL & GAS, INC. Rowling Robert B. 10% owner Crude Petroleum & Natural Gas BUY $9.75 512,821 $5,000,005 9,805,919 +5.5%
2021-02-09 23:09 2021-02-09 TERN Terns Pharmaceuticals, Inc. ORBIMED ADVISORS LLC Director, 10% owner Pharmaceutical Preparations BUY $17.00 475,000 $8,075,000 2,274,723 +26.4%
2021-02-09 22:55 2021-02-09 TERN Terns Pharmaceuticals, Inc. Flynn James E 10% owner, Other Pharmaceutical Preparations BUY $17.00 665,000 $11,305,000 2,382,033 +38.7%
2021-02-09 04:04 2020-02-04 N/A N/A SPC Field Partners LLC 10% owner Other BUY $19.39 207,094 $4,015,545 300,317 +222.1%
2021-02-09 02:08 2021-02-08 LABP N/A Poukalov Konstantin Director, 10% owner Other BUY $16.00 1,250,000 $20,000,000 14,619,728 +9.3%
2021-02-09 05:43 2021-02-04 PCPL N/A Atalan Capital Partners, LP 10% owner Other BUY $11.03 574,500 $6,336,735 4,436,975 +14.9%
2021-02-08 19:05 2020-10-01 XPMIX N/A StepStone Group LP Other Other BUY $25.00 80,000 $2,000,000 80,000 +100.0%
2021-02-08 17:45 2021-02-04 LABP N/A RTW INVESTMENTS, LP 10% owner Other BUY $16.00 625,000 $10,000,000 625,000 +100.0%
2021-02-08 18:52 2021-01-01 N-A N/A Partners Group Finance USD IC Ltd Other Other BUY $6.79 2,381,636 $16,164,639 2,381,636 +100.0%
2021-02-09 04:06 2020-02-04 N/A N/A SPC Wilson Point, L.P. 10% owner Other BUY $19.39 266,578 $5,168,955 498,860 +114.8%
2021-02-09 02:37 2021-02-08 LABP N/A PERCEPTIVE ADVISORS LLC Director, 10% owner Other BUY $16.00 1,250,000 $20,000,000 7,049,564 +21.6%
2021-02-06 01:08 2021-02-04 JWSM Jaws Mustang Acquisition Corp Reidler Michael Officer - Chief Financial Officer Blank Checks BUY $10.00 100,000 $1,000,000 100,000 +100.0%
2021-02-06 00:25 2021-02-05 N/A N/A PECHTER JOSHUA S Director Other BUY $200,002.00 18,182 $3,636,436,364 64,546 +39.2%
2021-02-05 21:12 2021-02-04 HOG HARLEY-DAVIDSON, INC. ZEITZ JOCHEN Director, Officer - President and CEO Motorcycles, Bicycles & Parts BUY $32.47 30,800 $1,000,165 253,720 +13.8%
2021-02-06 01:07 2021-02-04 JWSM Jaws Mustang Acquisition Corp HELFAND DAVID Director Blank Checks BUY $10.00 100,000 $1,000,000 100,000 +100.0%
2021-02-04 23:00 2021-02-02 BCACU N/A Brookline Capital Holdings LLC 10% owner Other BUY $10.00 247,000 $2,470,000 1,627,000 +17.9%
2021-02-05 03:08 2021-02-03 N-A N/A LEGG MASON, INC. 10% owner, Other Other BUY $10.20 828,431 $8,450,000 5,148,181 +19.2%
2021-02-05 04:54 2021-02-03 OTLK Outlook Therapeutics, Inc. Syntone Ventures LLC 10% owner Biological Products, (No Diagnostic Substances) BUY $1.00 3,000,000 $3,000,000 19,823,045 +17.8%
2021-02-04 21:34 2021-02-02 GIM Saba Capital Income & Opportunities Fund II Saba Capital Management, L.P. 10% owner Other BUY $5.63 615,992 $3,468,035 24,565,016 +2.6%
2021-02-04 17:45 2021-02-02 DCOM Dime Community Bancshares, Inc. /NY/ BASSWOOD PARTNERS, L.L.C. Director, 10% owner, Other National Commercial Banks BUY $25.39 70,011 $1,777,782 89,585 +357.7%
2021-02-05 01:16 2021-02-03 TSRI N/A FITZGERALD ROBERT E Director, 10% owner Other BUY $7.25 348,414 $2,526,002 487,614 +250.3%
2021-02-05 01:56 2021-02-02 EVLO Evelo Biosciences Inc. Flagship Ventures Fund IV General Partner LLC 10% owner Pharmaceutical Preparations BUY $15.00 130,000 $1,950,000 4,125,461 +3.3%
2021-02-04 17:44 2021-02-02 DCOM Dime Community Bancshares, Inc. /NY/ BASSWOOD CAPITAL MANAGEMENT, L.L.C. Director, 10% owner, Other National Commercial Banks BUY $25.39 272,329 $6,915,223 89,585 +100.0%
2021-02-05 02:47 2020-02-02 CFV N/A CFAC Holdings V, LLC 10% owner Other BUY $10.00 600,000 $6,000,000 600,000 +100.0%
2021-02-05 03:22 2021-02-03 YTEN N/A SCHULER JACK W 10% owner Other BUY $12.25 101,400 $1,242,150 895,035 +12.8%
2021-02-04 03:59 2021-01-01 N-A N/A Partners Group Finance USD IC Ltd Other Other BUY $4.81 2,383,163 $11,473,739 2,132 +100.0%
2021-02-03 05:11 2021-02-02 BLUA N/A BlueRiver Ventures, LLC 10% owner Other BUY $10.00 725,000 $7,250,000 725,000 +100.0%
2021-02-02 18:22 2021-02-01 SRGA N/A Lewicki Pawel Director Other BUY $1.50 2,000,000 $3,000,000 2,012,381 +16,153.8%
2021-02-03 00:52 2021-01-31 RCUS Arcus Biosciences, Inc. GILEAD SCIENCES INC 10% owner Pharmaceutical Preparations BUY $39.00 5,650,000 $220,350,000 13,913,029 +68.4%
2021-02-03 01:32 2021-02-02 OTLK Outlook Therapeutics, Inc. Sukhtian Ghiath M. Director, 10% owner Biological Products, (No Diagnostic Substances) BUY $1.00 8,360,000 $8,360,000 10,820,630 +339.8%
2021-02-02 18:30 2021-02-01 SRGA N/A Rich Terry M. Director, Officer - President and CEO Other BUY $1.50 808,204 $1,212,306 1,100,936 +276.1%
2021-02-02 17:22 2021-01-29 GIM Saba Capital Income & Opportunities Fund II Saba Capital Management, L.P. 10% owner Other BUY $5.61 422,918 $2,371,893 23,949,024 +1.8%
2021-02-03 05:10 2021-02-02 BLUA N/A MAYS RANDALL THOMAS Director, Officer, 10% owner - Co-CEO and CFO Other BUY $10.00 725,000 $7,250,000 725,000 +100.0%
2021-02-03 05:31 2021-02-02 BLUA N/A GREGG JOHN F Director, Officer, 10% owner - Co-Chief Executive Officer Other BUY $10.00 725,000 $7,250,000 725,000 +100.0%
2021-02-02 14:15 2021-01-29 DZSI N/A DASAN NETWORKS, INC 10% owner Other BUY $14.00 600,000 $8,400,000 10,093,015 +6.3%
2021-02-03 05:42 2021-01-29 MSM MSC INDUSTRIAL DIRECT CO INC JACOBSON MITCHELL Director, 10% owner Wholesale-Industrial Machinery & Equipment BUY $78.04 67,796 $5,290,780 67,796 +100.0%
2021-02-02 00:19 2021-01-28 N/A N/A RESSLER RICHARD S 10% owner Other BUY $25.63 156,067 $4,000,000 348,067 +81.3%
2021-02-02 00:18 2021-01-28 N/A N/A CIM RACR, LLC 10% owner Other BUY $25.63 156,067 $4,000,000 344,067 +83.0%
2021-02-02 03:09 2021-01-28 N/A Trinity Capital Inc. Eagle Point Credit Management LLC 10% owner Other BUY $14.00 357,142 $4,999,988 357,142 +100.0%
2021-02-02 00:19 2021-01-28 N/A N/A Kuba Shaul 10% owner Other BUY $25.63 156,067 $4,000,000 348,067 +81.3%
2021-02-02 00:18 2021-01-28 N/A N/A Shemesh Avraham 10% owner Other BUY $25.63 156,067 $4,000,000 348,067 +81.3%
2021-02-02 01:31 2021-01-28 VYNE VYNE Therapeutics Inc. PERCEPTIVE ADVISORS LLC 10% owner Pharmaceutical Preparations BUY $2.37 4,219,409 $9,999,999 27,095,819 +18.4%
2021-01-30 00:36 2021-01-29 TDY TELEDYNE TECHNOLOGIES INC MEHRABIAN ROBERT Director, Officer - Executive Chairman Search, Detection, Navigation, Guidance, Aeronautical Sys BUY $366.05 10,000 $3,660,462 168,370 +6.3%
2021-01-28 23:51 2021-01-28 N/A N/A MASSACHUSETTS MUTUAL LIFE INSURANCE CO 10% owner Other BUY $21.58 185,357 $4,000,000 142,947 +100.0%
2021-01-29 04:02 2021-01-27 PDO PIMCO Dynamic Income Opportunities Fund Hall Gregory Weston Other Other BUY $20.00 50,000 $1,000,000 50,000 +100.0%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.